Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Isoform-specific Inhibition of N-methyl-D-aspartate Receptors by Bile Salts.
Koch A
,
Bonus M
,
Gohlke H
,
Klöcker N
.
???displayArticle.abstract???
The N-methyl-D-aspartate subfamily of ionotropic glutamate receptors (NMDARs) is well known for its important roles in the central nervous system (CNS), e.g. learning and memory formation. Besides the CNS, NMDARs are also expressed in numerous peripheral tissues including the pancreas, kidney, stomach, and blood cells, where an understanding of their physiological and pathophysiological roles is only evolving. Whereas subunit composition increases functional diversity of NMDARs, a great number of endogenous cues tune receptor signaling. Here, we characterized the effects of the steroid bile salts cholate and chenodeoxycholate (CDC) on recombinantly expressed NMDARs of defined molecular composition. CDC inhibited NMDARs in an isoform-dependent manner, preferring GluN2D and GluN3B over GluN2A and GluN2B receptors. Determined IC50 values were in the range of bile salt serum concentrations in severe cholestatic disease states, pointing at a putative pathophysiological significance of the identified receptor modulation. Both pharmacological and molecular simulation analyses indicate that CDC acts allosterically on GluN2D, whereas it competes with agonist binding on GluN3B receptors. Such differential modes of inhibition may allow isoform-specific targeted interference with the NMDAR/bile salt interaction. In summary, our study provides further molecular insight into the modulation of NMDARs by endogenous steroids and points at a putative pathophysiological role of the receptors in cholestatic disease.
Awobuluyi,
Subunit-specific roles of glycine-binding domains in activation of NR1/NR3 N-methyl-D-aspartate receptors.
2007, Pubmed
Awobuluyi,
Subunit-specific roles of glycine-binding domains in activation of NR1/NR3 N-methyl-D-aspartate receptors.
2007,
Pubmed
Chatterton,
Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits.
2002,
Pubmed
,
Xenbase
Chen,
Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes.
2008,
Pubmed
,
Xenbase
Curras,
Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors.
1992,
Pubmed
,
Xenbase
Dehpour,
Effect of NMDA receptor antagonist on naloxone-precipitated withdrawal signs in cholestatic mice.
2000,
Pubmed
Erreger,
Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors.
2007,
Pubmed
,
Xenbase
Friesner,
Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.
2006,
Pubmed
Friesner,
Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.
2004,
Pubmed
Furukawa,
Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core.
2003,
Pubmed
Genheden,
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities.
2015,
Pubmed
Gertzen,
Mutational mapping of the transmembrane binding site of the G-protein coupled receptor TGR5 and binding mode prediction of TGR5 agonists.
2015,
Pubmed
Glantz,
Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates.
2004,
Pubmed
Gohlke,
Converging free energy estimates: MM-PB(GB)SA studies on the protein-protein complex Ras-Raf.
2004,
Pubmed
Gowert,
Defective Platelet Activation and Bleeding Complications upon Cholestasis in Mice.
2017,
Pubmed
Gómez-Vicente,
Neuroprotective Effect of Tauroursodeoxycholic Acid on N-Methyl-D-Aspartate-Induced Retinal Ganglion Cell Degeneration.
2015,
Pubmed
Halgren,
Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.
2004,
Pubmed
Hamelberg,
Accelerated molecular dynamics: a promising and efficient simulation method for biomolecules.
2004,
Pubmed
Harder,
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins.
2016,
Pubmed
Hasanein,
Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate.
2007,
Pubmed
Hogan-Cann,
Physiological Roles of Non-Neuronal NMDA Receptors.
2016,
Pubmed
Hollmann,
Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor.
1993,
Pubmed
,
Xenbase
Homeyer,
Binding Free Energy Calculations for Lead Optimization: Assessment of Their Accuracy in an Industrial Drug Design Context.
2014,
Pubmed
Hopkins,
Long-Time-Step Molecular Dynamics through Hydrogen Mass Repartitioning.
2015,
Pubmed
Horak,
Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate.
2006,
Pubmed
Hosseini,
Effects of CA1 glutamatergic systems upon memory impairments in cholestatic rats.
2013,
Pubmed
Hou,
Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations.
2011,
Pubmed
Humphrey,
VMD: visual molecular dynamics.
1996,
Pubmed
Jang,
A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity.
2004,
Pubmed
,
Xenbase
Katoh,
MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization.
2019,
Pubmed
Keitel,
Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
2005,
Pubmed
Kleckner,
Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes.
1988,
Pubmed
,
Xenbase
Kuzmanic,
Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors.
2010,
Pubmed
Li,
The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling.
2011,
Pubmed
MacDermott,
NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones.
,
Pubmed
Makino,
Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases.
1975,
Pubmed
Malayev,
Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids.
2002,
Pubmed
,
Xenbase
Mano,
Presence of protein-bound unconjugated bile acids in the cytoplasmic fraction of rat brain.
2004,
Pubmed
Mayer,
Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones.
,
Pubmed
Miller,
MMPBSA.py: An Efficient Program for End-State Free Energy Calculations.
2012,
Pubmed
Onufriev,
Exploring protein native states and large-scale conformational changes with a modified generalized born model.
2004,
Pubmed
Paoletti,
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.
2013,
Pubmed
Pierce,
Routine Access to Millisecond Time Scale Events with Accelerated Molecular Dynamics.
2012,
Pubmed
Pilo de la Fuente,
Cerebrotendinous xanthomatosis: neuropathological findings.
2008,
Pubmed
Plattner,
Protein conformational plasticity and complex ligand-binding kinetics explored by atomistic simulations and Markov models.
2015,
Pubmed
Richieri,
Mutants of rat intestinal fatty acid-binding protein illustrate the critical role played by enthalpy-entropy compensation in ligand binding.
1997,
Pubmed
Roe,
PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data.
2013,
Pubmed
Schmidt,
The bile acid-sensitive ion channel (BASIC) is activated by alterations of its membrane environment.
2014,
Pubmed
,
Xenbase
Schmidtke,
MDpocket: open-source cavity detection and characterization on molecular dynamics trajectories.
2011,
Pubmed
Schmidtke,
Understanding and predicting druggability. A high-throughput method for detection of drug binding sites.
2010,
Pubmed
Schubring,
The bile steroid chenodeoxycholate is a potent antagonist at NMDA and GABA(A) receptors.
2012,
Pubmed
Sherman,
Novel procedure for modeling ligand/receptor induced fit effects.
2006,
Pubmed
Tajima,
Activation of NMDA receptors and the mechanism of inhibition by ifenprodil.
2016,
Pubmed
Tan,
How well does Poisson-Boltzmann implicit solvent agree with explicit solvent? A quantitative analysis.
2006,
Pubmed
Traynelis,
Glutamate receptor ion channels: structure, regulation, and function.
2010,
Pubmed
Tripodi,
Bile acids content in brain of common duct ligated rats.
2012,
Pubmed
Tsui,
Theory and applications of the generalized Born solvation model in macromolecular simulations.
,
Pubmed
Vance,
Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors.
2011,
Pubmed
Weis,
Ligand affinities predicted with the MM/PBSA method: dependence on the simulation method and the force field.
2006,
Pubmed
Yao,
Molecular mechanism of ligand recognition by NR3 subtype glutamate receptors.
2008,
Pubmed
Ye,
GLProbs: Aligning Multiple Sequences Adaptively.
2015,
Pubmed
Yi,
Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.
2016,
Pubmed
,
Xenbase
